This inventor holds 4 USPTO granted patents. Top assignees: Day Zero Diagnostics, Inc., Biomerieux, Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: The Innovations of Chiahao Tsui
Introduction
Chiahao Tsui is an accomplished inventor based in Somerville, MA (US). He has made significant contributions to the field of clinical diagnostics, particularly in the preparation and analysis of nucleic acids. With a total of 4 patents to his name, Tsui's work is paving the way for advancements in medical technology.
Latest Patents
One of Tsui's latest patents is a method of preparing clinical samples for nucleic acid amplification. This method involves the use of host cells, microbes, proteins, and a polyanionic polymer nucleic acid amplification inhibitor. Another notable patent is focused on the selective enrichment of a population of DNA in a mixed DNA sample through targeted suppression of DNA amplification. This innovation provides methods and products for selectively enriching one population of DNA in a mixed sample, which is particularly useful in clinical settings where pathogenic microbial DNA is present alongside mammalian host DNA.
Career Highlights
Chiahao Tsui is currently employed at Day Zero Diagnostics, Inc., where he continues to develop innovative solutions for clinical diagnostics. His work is instrumental in enhancing the accuracy and efficiency of nucleic acid testing, which is crucial for diagnosing infections and other medical conditions.
Collaborations
Tsui collaborates with notable colleagues such as Melis Nuray Anahtar and Dougal Maclaurin. Their combined expertise contributes to the advancement of research and development in the field of diagnostics.
Conclusion
Chiahao Tsui's contributions to the field of clinical diagnostics through his innovative patents and collaborations highlight his role as a leading inventor. His work is essential for improving medical testing and patient outcomes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
